Insider-Kauf: Surgery Partners
© MT Newswires 2022
Alle Nachrichten zu SURGERY PARTNERS, INC. |
|
|
|
News auf Englisch zu SURGERY PARTNERS, INC. |
|
09.01. | Surgery Partners Maintains 2022 Revenue Outlook | MT |
09.01. | Surgery Partners, Inc. : Results of Operations and Financial Condition (form 8-K) | AQ |
09.01. | Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance | AQ |
09.01. | Surgery Partners, Inc. Reaffirms Revenue Guidance for 2022 | CI |
06.01. | Certain Common Stock of Surgery Partners, Inc. are subject to a Lock-Up Agreement Endin.. | CI |
03.01. | Surgery Partners, Inc. To Present At Upcoming Investor Conference | AQ |
2022 | Surgery Partners, Inc. : Unregistered Sale of Equity Securities, Other Events, Financial S.. | AQ |
2022 | Surgery Partners, Inc. announced that it has received $224.999989 million in funding fr.. | CI |
2022 | Surgery Partners' Secondary Offering Should Help Ease Balance Sheet Doubts, RBC Says | MT |
2022 | Insider Buy: Surgery Partners | MT |
|
|
Analystenempfehlungen zu SURGERY PARTNERS, INC. |
|
|
| |
|
Umsatz 2022 |
2 521 Mio
-
2 323 Mio
|
Nettoergebnis 2022 |
-15,9 Mio
-
-14,7 Mio
|
Nettoverschuldung 2022 |
2 213 Mio
-
2 039 Mio
|
KGV 2022 |
-186x |
Dividendenrendite 2022 |
- |
|
Marktwert |
4 347 Mio
4 347 Mio
4 006 Mio
|
Marktwert / Umsatz 2022 |
2,60x |
Marktwert / Umsatz 2023 |
2,39x |
Mitarbeiterzahl |
9 600 |
Streubesitz |
47,2% |
|
Chart SURGERY PARTNERS, INC. |
|
Dauer :
Zeitraum :
|
 |
|
Chartanalyse-Trends SURGERY PARTNERS, INC.
| Kurzfristig | Mittelfristig | Langfristig | Trends | Ansteigend | Neutral | Fallend |
|
Durchschnittl. Empfehlung |
KAUFEN |
Anzahl Analysten |
10 |
Letzter Schlusskurs |
35,94 $ |
Mittleres Kursziel |
44,40 $ |
Abstand / Durchschnittliches Kursziel |
23,5% |
Verlauf des Gewinns je Aktie
Vorstände und Aufsichtsräte
|